Orion Corporation

Finnish pharmaceutical company

Nasdaq Helsinki ISIN FI0009014377 LEI 74370029VAHCXDR7B745
Follow Orion Weekly email: filings, results

Financials

Reported figures only · latest: fiscal 2025 EUR · IFRS
Revenue, last year €1.9B +22.5% vs prior year
Net income €500.3M +51.7% vs prior year
EPS, diluted €3.56 +51.5% vs prior year
Operating cash flow €316.8M +8% vs prior year
Revenue by fiscal year
€1.1B
€1B
€1.3B
€1.2B
€1.5B
€1.9B
FY20 FY21 FY22 FY23 FY24 FY25

Source: ESEF annual reports · latest filing

The long view

Fiscal years as reported · ESEF annual reports, IFRS
Revenue and net income7 fiscal years
  • Revenue
  • Net income
€0€500M€1B€1.5B€2BFY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25€1.9B€500.3M
FY24€1.5B€329.9M
FY23€1.2B€216.8M
FY22€1.3B€349.5M
FY21€1B€193.8M
FY20€1.1B€219.9M
FY19€1.1B€200.4M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
0%20%40%60%80%FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2564.2%33.4%26.5%
FY2461.4%27%21.4%
FY2355.3%23.1%18.2%
FY2263.3%32.8%26.1%
FY2157%23.4%18.6%
FY2060.4%26%20.4%
FY1960.3%24.1%19.1%
Free cash flowOperating cash flow minus capital expenditure
€0€100M€200M€300M€400MFY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25€243.4M
FY24€231.1M
FY23€53.4M
FY22€377.9M
FY21€168.7M
FY20€265.1M
FY19€242.1M
Returned to shareholdersDividends paid and shares bought back
  • Dividends
  • Buybacks
€0€100M€200M€300MFY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearDividendsBuybacks
FY25€231.1M-
FY24€228M€0
FY23€224.9M-
FY22€211.2M€17.9M
FY21€211.2M-
FY20€211.1M-
FY19€211.2M€7.4M
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Orion
  • Healthcare median
−100%−50%0%50%FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearOrionHealthcare median
FY2526.5%−30.6%
FY2421.4%−47%
FY2318.2%−58%
FY2226.1%−80.4%
FY2118.6%−71.9%
FY2020.4%−62.2%
FY1919.1%−46.3%